Get exclusive access to our brand new Whitepaper "mHealth: Transforming Healthcare and Driving Business for Pharmaceutical Companies." Click here: http://bit.ly/1x21JaM It’s free.

1. Transforming Healthcare and Driving Business for Pharmaceutical Companies
mHealth
1

2. Index
Executive Summary
Introduction
1. Consumers driving mHealth market
2. The mHealth app market: data and future trends
3. Privacy and security of mHealth solutions
4. The impact of mobile apps on health care
5. mHealth and new models of care
Conclusion
Sources
2

3. Executive summary
The rapid adoption of smartphones has spawned a growing industry of digital health and wellness solutions marketed directly to consumers. Consumers are using mobile devices and apps to support their health and to monitor their health conditions. The adoption of this technology is enabling transformations in how care delivery is organized as well as introducing new channels of communication between clinicians and patients. These technologies can enable important transformations in the way in which care is organized and delivered to many patient populations including those living with chronic conditions. Mobile health (mHealth) holds great promise to enhance treatment outcomes while mitigating health care costs. It can improve patient convenience and safety, and support interactions with care providers. Consequently Pharmaceutical companies are deploying new mobile technologies to achieve better care outcomes, reduced costs and increased patient engagement. This white paper covers the effective use of mobile devices in health care delivery, specifically related to clinician and patient interactions. This white paper is written for senior decision makers in clinical and health IT roles who are responsible for enterprise transformations through the use of enabling technologies. It serves to cover the effective use of mobile devices and apps by patients and their relevance to the digital health community. It provides clarification on the definition and characteristics of mHealth for consumers, its economic value, deployment models and implementation considerations including architecture, interoperability and privacy and security. Key questions of white paper are:
What is driving adoption of mHealth?
How is mobility driving business for pharmaceutical companies?
3

4. Introduction
The adoption of mobile technologies in every dimension of life has been phenomenal. In the span of two decades, ever-more sophisticated mobile technology has fundamentally altered the ways in which people communicate and conduct business. The disruptive power of these new technologies and the accompanying waves of innovation they have sparked are transforming the health care industry, propelling pharmaceutical companies to reassess and repurpose how they provide services. The health care and life sciences industry is recognized as one of the top three fields likely to propel mobile device growth in the next five years. Transformative trends in the industry are conducive to remarkable growth in mobile applications - population aging, increasing chronic illness, accelerating health costs, new regulatory reforms and increased consumer demand for health information and self-care will drive mobile solution growth. In addition, the industry is capital-intense, highly regulated and labor-intensive. Digital technologies, including mobile devices, can play a key role in transforming health care into a more-efficient, patient-centered system of care in which individuals have instant, on-demand access to their medical records and powerful clinical decision support tools that empower them to actively participate in their treatment plans. As applications become more user-friendly and technologies expand their reach to remote populations, they will be seamlessly integral to the provision and financing of health services. Here are some definitions to help you read this white paper. Gartner, a leading American information technology research and advisory firm, describes mHealth as being similar to e-health in that it is a broad and nebulous concept that emphasizes the means (mobile device technologies and apps), not the end (actual use of mobile technologies in health care delivery). Gartner believes that as mobile technologies become incorporated into health service delivery, the term “mHealth” will become obsolete.
4

5. Introduction
We define mHealth as medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, tablets, personal digital assistants, and other wireless devices. The ubiquity of mobile devices in both developed and developing countries presents an opportunity to improve health outcomes through the innovative delivery of health services and information. A Mobile application definition sourced from Technopedia.com is as follows: “a mobile application, most commonly referred to as an app, is a type of application software designed to run on a mobile device, such as a smartphone or tablet computer. Mobile devices also have the capability to run browser based applications similar to PCs. Browser based applications are common in the mHealth space especially when providing access to existing applications and services that are already web enabled. These types of applications typically do not use mobile device specific capabilities or information presentation tools and do not store information collected on the mobile device. The use of new protocols such as HTLM5, will, over time, allow web-based apps to offer similar functionality as found in mobile apps (e.g., touch screen access; storing of information on mobile devices; access to location data). Remote patient monitoring is the delivery of health care to a patient’s home, made possible by connecting the patient and a health care provider through a technology device. It involves the electronic transmission of patient data (e.g., symptoms, vital signs, outcomes) to the provider at a remote location, data review and interpretation and potential alteration of the patient’s course of care. Remote patient monitoring does not work equally well for all patients. It is influenced by patient characteristics and state of disease.
5

6. mHealth holds great promise to enhance treatment outcomes while mitigating health care costs.
“
It can improve patient convenience and safety, and support interactions with care providers.
“
6

7. 7